San Diego, CA, United States of America

Mehrnouch Motamedi

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Ligand Pharmaceuticals, Inc.. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mehrnouch Motamedi. Retrieved from https://idiyas.com/inventor/mehrnouch-motamedi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 58(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mehrnouch Motamedi: Innovator in Pharmaceutical Modulation

Introduction

Mehrnouch Motamedi is a notable inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that modulate androgen and progesterone receptors. His work is essential for advancing therapeutic options in various medical conditions.

Latest Patents

Motamedi holds a patent for "Bicyclic androgen and progesterone receptor modulator compounds and methods." This invention focuses on nonsteroidal compounds and compositions that act as high-affinity, high-specificity agonists, partial agonists, and antagonists for androgen and progesterone receptors. The patent outlines methods for synthesizing these compounds and their pharmaceutical compositions, which are crucial for modulating processes mediated by these receptors.

Career Highlights

Currently, Mehrnouch Motamedi is associated with Ligand Pharmaceuticals, Inc. His role at the company allows him to leverage his expertise in pharmaceutical development and innovation. With a patent portfolio that includes 1 patent, he continues to contribute to the advancement of medical science.

Collaborations

Motamedi has worked alongside talented colleagues such as Lin Zhi and Christopher Michael Tegley. Their collaborative efforts enhance the research and development processes within their field.

Conclusion

In summary, Mehrnouch Motamedi is a distinguished inventor whose work in pharmaceutical modulation has the potential to impact medical treatments significantly. His innovative approaches and collaborations continue to drive advancements in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…